Mediating Effects of Plasma Metabolites in Inflammatory Protein-Lymphoma Causality: A Mendelian Randomization Study
Plasma inflammatory proteins causally influence DLBCL risk, partially mediated by metabolites. This underscores metabolite pathways as potential targets for therapeutic intervention.
Authors
- Xiaotong Gao (ORCID: https://orcid.org/0000-0002-7798-0321)
- Li Liu (ORCID: https://orcid.org/0000-0002-4490-2159)
- Weiwei Qin (ORCID: https://orcid.org/0000-0001-7987-1658)
- Zhuo Wan (ORCID: https://orcid.org/0000-0003-3202-2776)
- Yueru Ji
Institutions
- Tang Du Hospital (CN)
Publication Details
- Journal
- Current Medicinal Chemistry
- Published
- 2025-10-02
- DOI
- https://doi.org/10.2174/0109298673382735250904071151
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00